Skip to main content

Juan Ignacio Esteban Mur

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Juan Ignacio Esteban Mur

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Dynamically individualized treatment of hepatitis C infection and correlates of viral/host dynamics

IP: Juan Ignacio Esteban Mur
Collaborators: -
Funding agency: EUROPEAN COMMISSION
Funding: 135700
Reference: QLK2-2000-00836
Duration: 01/12/2000 - 01/12/2003

CIBER Enfermedades hepáticas y digestivas (CIBEREHD)

IP: Juan Ignacio Esteban Mur
Collaborators: Josep Quer Sivila
Funding agency: CIBER Enfermedades Hepáticas y Digestivas
Funding:
Reference: CB06/04/0028
Duration: 01/01/2007 - 31/12/2010

Selección y expansión de linfocitos CD4+NS3-específicos de pacientes VHC. caracterización del estado de anergia en cronicidad y restauración funcional para empleo en inmunoterapia adaptativa para prevención y tratamiento de la recurrencia postrasplante.

IP: Josep Quer Sivila
Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté, Juan Ignacio Esteban Mur
Funding agency: Instituto de Salud Carlos III
Funding: 113740
Reference: PI061244
Duration: 01/01/2007 - 30/12/2009

Seleción y expansión de linfocitos T CD4+NS3-específicos de pacientes coinfectados por VIH y VHC. caracterización del estado de anergia en la infección crónica y restauración funcional para su empleo en inmunoterapia adaptativa para la prevención y/o tratamiento de la recurrencia postransplante

IP: Juan Ignacio Esteban Mur
Collaborators: Josep Quer Sivila
Funding agency: Fundación Innov. y Prosp. Salud en España - FIPSE
Funding: 85800
Reference: FIPSE/36623/06
Duration: 01/12/2006 - 30/11/2009

Related news

The results, published in The Lancet and Nature Medicine, provide new evidence to improve the diagnosis of metabolic dysfunction-associated steatotic liver disease and reduce the need for liver biopsies.

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The grants support projects led by Drs. María José Buzón, María Buti, Elena Élez, and Maria Vieito.

Related professionals

Maria Emilia Dip Pérez

Maria Emilia Dip Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Sandra Castro Boix

Sandra Castro Boix

Predoctoral researcher
General Surgery
Read more
Rosa Burgos Peláez

Rosa Burgos Peláez

Research technician
Diabetes and Metabolism
Read more
Ramon Martí Seves

Ramon Martí Seves

Head of group
Neuromuscular and Mitochondrial Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.